Opportunity
Simpler Grants.gov #FOR-AI-27-008
NIAID Investigator-Initiated Research Program Project Applications for Allergy and Infectious Diseases
Buyer
National Institutes of Health
Posted
June 16, 2025
Respond By
January 25, 2026
Identifier
FOR-AI-27-008
NAICS
541715
This opportunity from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, invites investigator-initiated program project applications to advance research in allergy, infectious diseases, and immune system function. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - OEMs and Vendors: - No specific Original Equipment Manufacturers (OEMs) or vendors are named, as this is a research grant opportunity. - Products/Services Requested: - Research proposals in the following areas: - Biology, pathogenesis, and host response to microbes - Mechanisms regulating immune system development and function - Immune dysfunction (autoimmunity, immunodeficiency, allergy, asthma, transplant rejection) - Translational research for vaccines, therapeutics, and diagnostics for infectious, immune-mediated, and allergic diseases - No specific products, part numbers, or purchase quantities are listed - Unique or Notable Requirements: - Open to a wide range of eligible applicants, including government entities, educational institutions, businesses, and nonprofit organizations - Focus is on advancing scientific research rather than procurement of goods or services
Description
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking investigator-initiated program project applications in scientific areas relevant to its mission. These areas include the biology, pathogenesis, and host response to microbes; immune system development and function; immune dysfunction such as autoimmunity and allergy; and translational research for vaccines, therapeutics, and diagnostics. The program supports research to prevent and treat infectious, immune-mediated, and allergic diseases. Eligible applicants include government entities, educational institutions, businesses, and nonprofit organizations.